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Abstract: 
The pedunculopontine nucleus (PPN) is a reticular nucleus located in the 
mesencephalic and upper pontine tegmentum. Initially, characterized by its 
predominant cholinergic projection neurons, it was associated with the 
“mesencephalic locomotor region” and “reticular activating system”. Furthermore, 
based on histopathological studies, the PPN was hypothesized to play a role in the 
manifestation of symptoms in movement disorders such as Parkinson`s disease 
(PD). Since axial symptoms represent unmet needs of PD treatments, a series of 
pioneering experiments in Parkinsonian monkeys promoted the idea of a potential 
new target for deep brain stimulation (DBS) and much clinical interest was generated 
in the following years leading to a number of trials analysing the role of PPN for gait 
disorders. This review summarizes the historical background and more recent 
findings about the anatomy and function of the PPN and its implications in the basal 
ganglia network of the normal as well as diseased brain. Classical views on PPN 
function shall be challenged by more recent findings. Additionally, the current role 
and future perspectives of PPN DBS in PD patients shall be outlined. 
Keywords: Deep Brain Stimulation, Gait disorders, Pedunculopontine, nucleus, Review  
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Introduction: 
Several independent findings based on animal models as well as in humans have 
indicated a role of the pedunculopontine nucleus (PPN) in motor function over the 
past few decades. The PPN is located in the mesencephalic and upper pontine 
tegmentum and was classically identified by its predominant cholinergic neurons. 
Based on its widespread connections to other areas of the brain and spinal cord, the 
PPN is involved in a variety of functions. Most importantly with regard to clinical 
implications, altered PPN function in a parkinsonian model of non-human primates 
promoted the idea of this nucleus to be a possible new target for treating motor 
symptoms in Parkinson`s disease (PD) as early as 1989 (Mitchell et al., 1989). 
Consecutive primate studies supported the concept that PPN plays a crucial role in 
motor function. Particularly, high-frequency stimulation of the PPN was reported to 
reduce motor activity in the intact non-human monkey and low-frequency PPN-DBS 
could successfully improve motor activity in a primate model of PD (Jenkinson et al., 
2004; Nandi et al., 2002b). Based on these and other pioneering findings, the PPN 
was targeted in humans in order to treat predominantly gait disturbances associated 
with Parkinson`s disease or other movement disorders (Pereira et al., 2008; Stefani 
et al., 2007). However, initial enthusiasm about this promising new target was 
dampened by mixed outcome results of PPN DBS reported by different centers in the 
course of the following years (Hamani et al., 2011). Parallel to clinical studies 
analysing the effect of PPN-DBS, a tremendous number of animal studies has refined 
our understanding of the PPN and its involvement in many neurophysiological 
processes beyond motor function such as regulation of the sleep-wake-cycle, 
involvement in reward circuits and influence of behavioural decision-making (Mena-
Segovia and Bolam, 2017; Winn, 2006). This review article aims to give a brief 
historical background and to report on more recent findings about the anatomy and 
function of the PPN and its implications in the basal ganglia network of the normal as 
well as diseased brain. Furthermore, the current and future role of PPN-DBS in 
humans shall be discussed.  
 
Anatomical considerations 
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The PPN is an evolutionary highly conserved structure which is found in almost every 
species that has so far been studied including fish, amphibians and vertebrates 
(Brantley and Bass, 1988; Honda and Semba, 1995; Marin et al., 1997; Rye et al., 
1987). The PPN was first described by Jacobson in 1909 based on neuroanatomical 
studies in humans (Jacobson, 1909). However, the first systematic approach to 
characterize the PPN dates back to 1954 when Olszewski and Baxter published their 
classic cytoarchitectonic study of the human PPN based on light microscopic analysis 
(Olszewski and Baxter, 1954). The PPN is located in the upper brainstem tegmentum 
at the junction of the midbrain and pons at the level of the inferior colliculus (Figure 
1). In humans, the PPN is located just below the red nucleus dorsally to the 
substantia nigra (SN) and extends caudally approximately 5-10 mm to the level of the 
locus coeruleus (Hamani et al., 2016a). The PPN lies medial and posterior to the 
lemniscus medialis and lateral to the decussating cerebellar fibers (brachium 
conjunctivum) and central tegmental tract. The functionally similar subcuneiform and 
cuneiform nucleus are located just dorsally to the PPN. According to Olszewski and 
Baxter the PPN was divided into two parts referring to the size and density of 
neurons: a pars compacta which is located in the caudal half of the nucleus and a 
pars dissipata which extends throughout the rostrocaudal axis of the PPN (Olszewski 
and Baxter, 1954). However, due to the fact, that the PPN is a reticular nucleus, 
definition of the exact borders seems arbitrary and since its initial description, 
different human brain atlases have described different rostrocaudal extents of the 
PPN based on cytoarchitectonical features (summarised in Hamani et al. 2016 
(Hamani et al., 2016a)). More recently, some authors have considered the division of 
the PPN into a pars compacta and reticulata as outdated with reference to a 
neurochemical and functional point of view (Mena-Segovia and Bolam, 2017). The 
reasons for this shall be discussed briefly. The PPN contains numerous cholinergic 
neurons giving rise to intense immunoreactivity to choline acetyltransferase (ChAT) 
and which correspond to the Ch5 group in the classification of Mesulam (Mesulam et 
al., 1989; Mesulam et al., 1983). Thus, based on immunostaining, the PPN 
boundaries can be clearly described and the distribution of cholinergic neurons within 
the PPN follows the concept of a subdivision of the nucleus into a pars compacta and 
pars reticulata: cholinergic neurons are estimated to make up 58 to 90% in the pars 
compacta and 16 to 75% in the pars reticulata subregion (Manaye et al., 1999; 
Mesulam et al., 1989). However, the PPN is a neurochemically heterogenous 
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structure that contains at least two other interdigitated projection neurons: GABAergic 
and glutamatergic (Wang and Morales, 2009). The relative frequencies of these 
neurochemically distinct cell types vary considerably between the subregions of the 
PPN and do not follow the same distribution of the cholinergic neurons. GABAergic 
neurons are densely located in the rostral part of the PPN, some extending to the 
substantia nigra pars reticulata (SNr) (Mena-Segovia et al., 2009). Glutamatergic 
neurons are predominantly found in the caudal PPN (Clements and Grant, 1990). 
Thus, the distribution of different populations of neurons based on their expression of 
neurotransmitters does not equally follow the principle segregation of the PPN 
nucleus into two parts. Moreover, cholinergic neurons have been found to co-express 
a variety of neuropeptides such as substance P and atrial natriuretic peptide as well 
as nitric oxide (NO) but the exact co-expression patterns still need to be discerned 
(Moga and Saper, 1994; Vincent et al., 1983; Vincent et al., 1986). Furthermore, the 
principle segregation into a pars reticulata and pars compacta does not go along with 
functional aspects which seem to be arranged according to another topographical 
distribution (to be discussed below). 
Besides the classification of different neurons within the PPN according to the 
microscopic phenotype and the neurotransmitters that they express, in-vitro 
electrophysiological studies of the rat PPN have identified different cell types based 
on the membrane characteristics and the firing patterns. Morphologically small type I 
neurons were characterized by low-threshold Ca-spikes and bursting activity. Type II 
neurons displayed a transient outward potassium current with no bursting activity. A 
third type was described that revealed both of these current types and firing patterns 
(Kamondi et al., 1992; Luebke et al., 1992). All cell types were immunopositive for 
choline acetyltransferase at least to a certain degree. However, the exact 
neurochemical identity of each of the electrophysiologically distinct cell types remains 
unclear. Different cell types according to their firing patterns have also been found by 
microelectrode recording during PPN-DBS in humans. Cells could be classified 
according to random or burst-like activity patterns and according to low-frequency (8-
35 Hz) and high-frequency (60-70 Hz) firing patterns (Tattersall et al., 2014; 
Weinberger et al., 2008; Wilcox et al., 2011). Similar to the results of in-vitro models, 
the underlying phenotype of the different electrophysiological cell types remains 
unsolved. 
ACCEPTED MANUSCRIPT
AC
C
EP
TE
D
 M
AN
U
SC
R
IP
T
 
 
The PPN has numerous afferent and efferent connections to virtually all parts of the 
central nervous system (CNS). Figure 2 summarizes important afferent and efferent 
connections of the PPN. Listing these numerous afferent and efferent connections 
can be tedious, however, they can be easier appreciated and memorized when they 
are related to function. Although the functional aspects of the PPN are described in 
more detail below, some coarse principles shall already be mentioned here, that help 
categorize afferent and efferent connections of the PPN according to the functionally 
and anatomically partly overlapping networks into which the PPN is integrated. First, 
the PPN is integrated into the subcortical cerebello-thalamo-cortical and basal 
ganglia-thalamo-cortical networks regulating motor function (Garcia-Rill, 1991). Not 
surprisingly, the PPN receives input from the deep cerebellar nuclei and is highly 
interconnected with parts of the basal ganglia such as the striatum, internal pallidal 
segment (GPi), the subthalamic nucleus (STN) and SN and sends efferent fibers to 
the spinal cord and ventral tegmental area (VTA). Second, the PPN is involved in 
arousal and regulation of the sleep-wake-cycle (Garcia-Rill et al., 2015). Therefore, it 
is highly interconnected with parts of the reticular formation and brain stem nuclei, 
and sends widespread efferent fibers to the hypothalamus, thalamus and basal 
forebrain. With this concept in mind, many of the afferent and efferent connections 
that are systematically listed in the following paragraphs can be allocated to one of 
these functional networks. 
Most of our knowledge about the connectivity of the PPN comes from tracing studies 
of rats and other mammals with only some of them based on primates. It is important 
to mention, that the majority of analyses of efferent innervation patterns of the PPN is 
based on tracing studies and reconstruction of cholinergic neurons and much less is 
known about the connectivity of the non-cholinergic neurons, which, however, are 
estimated to outnumber cholinergic neurons by factor five at least in the rat (Mena-
Segovia et al., 2009; Wang and Morales, 2009). One important principle that has 
been demonstrated is that a single cholinergic neuron innervates concomitantly 
different target structures by means of numerous axon collaterals (Mena-Segovia et 
al., 2008a; Mena-Segovia et al., 2008b). Both ascending and descending 
connections have been described and can further be divided (Mena-Segovia and 
Bolam, 2017). (i) Ascending ventral axon collaterals innervate parts of the basal 
ganglia, amygdala, the basal forebrain and septum region as well as the lateral 
hypothalamus (Dautan et al., 2016a; Lavoie and Parent, 1994b; Mena-Segovia et al., 
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2004; Semba and Fibiger, 1992; Semba et al., 1988; Woolf and Butcher, 1986). In 
addition, intense efferent connections with dopaminergic neurons of the SNc and 
VTA as well as to the STN have been demonstrated by tracing experiments in rats 
and monkeys (Beninato and Spencer, 1987; Bevan and Bolam, 1995; Gould et al., 
1989; Lavoie and Parent, 1994a; Oakman et al., 1995). (ii) Ascending dorsal axon 
collaterals innervate the superior colliculi and widespread parts of the reticular, limbic, 
motor, sensory and associative thalamus (Ainge et al., 2004; Hallanger and Wainer, 
1988; Holmstrand and Sesack, 2011; Motts and Schofield, 2009; Pare et al., 1988; 
Smith et al., 1988; Steriade et al., 1988). (iii) Descending fibers have been 
demonstrated to innervate the pontine and medullary reticular formation, the motor 
trigeminal nucleus, serotonergic cells of the ascending reticular activating system 
(ARAS) as well as the pontine oralis and gigantocellular nucleus (Fay and Norgren, 
1997a; Fay and Norgren, 1997b; Martinez-Gonzalez et al., 2014; Mitani et al., 1988; 
Nakamura et al., 1989; Rye et al., 1987; Skinner et al., 1990b). Furthermore, efferent 
connections to the spinal cord have been described (Skinner et al., 1990a). There is 
still uncertainty about the extent of ascending and descending fibers that cross to the 
contralateral side. At least there is evidence of contralateral projections to the 
thalamus, but whether or not this example constitutes a general principle remains 
unclear (Usunoff et al., 1999). In summary, different widespread targets are 
innervated by PPN cholinergic neurons along separate parallel streamlines. If there is 
a somatotopical organization of cholinergic neurons within the PPN in terms of 
anatomically segregated neuron assemblies that innervate distinct targets remains an 
interesting hypothesis. First evidence in favour of this premise comes from 
optogenetic and recording studies in rats, which have shown that cholinergic neurons 
in the rostral part primarily innervate the dorsolateral striatum whereas cholinergic 
neurons within the caudal PPN innervate limbic dopaminergic neurons in the VTA 
(Dautan et al., 2014; Dautan et al., 2016b).  
Contrary to cholinergic neurons, non-cholinergic cells are less arbored and less is 
known about their connectivity patterns although the few findings that have been 
made point towards a considerable overlap with targets reached by cholinergic cells. 
According to tracing studies in monkeys and rats, glutamatergic neurons innervate 
the SNc, STN, VTA and thalamus (Barroso-Chinea et al., 2011; Bevan and Bolam, 
1995; Charara et al., 1996). Similarly, GABAergic PPN neurons have been 
demonstrated to send their axons to the STN and hypothalamus (Bevan and Bolam, 
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1995; Ford et al., 1995). As far as the STN is concerned, some evidence supports 
the concept that PPN strongly influences the activity of STN neurons. For instance, 
lesion of the PPN promoted a significant increase of STN firing discharge in 
Parkinsonian rats (Breit et al., 2006). Of note, during 25 Hz PPN-DBS the large 
majority of STN neurons change their activity in terms of firing rate and burst activity 
(Galati et al., 2008). 
Furthermore, important inputs to the PPN arise from the basal ganglia. Initial findings 
by Nauta and Mehler, that lesions of the GPi induced degeneration of the PPN in the 
monkey pointed already towards a connection between these structures that was 
later confirmed by tracing studies in rats, cats and monkeys (Carter and Fibiger, 
1978; Groenewegen et al., 1993; Nauta, 1979; Nauta and Mehler, 1966). Another 
nucleus of the basal ganglia which is interconnected with the PPN is the SN. While 
extensive efferent connections exist from the PPN to the SNc, the PPN receives 
strong input from the SNr (Spann and Grofova, 1991). Similarly, intense reciprocal 
connections exist between the STN and the PPN (Steininger et al., 1992). Besides 
intense reciprocal connections with different nuclei of the basal ganglia, tracer 
experiments in the rat and squirrel monkey have shown that the PPN receives input 
from the deep cerebellar output nuclei and red nucleus (Hazrati and Parent, 1992; 
Ruggiero et al., 1997). Furthermore, the PPN receives input from the motorcortex, 
premotor cortex as well as frontal eye fields in a somatotopically organized way, but 
this somatotopy overlapped to some considerable extent (Matsumura et al., 2000; 
Matsumura et al., 1997). Furthermore, tracer experiments in rats indicate that the 
PPN receives input from the extended amygdala (Zahm et al., 2001). Based on 
retrograde tracing experiments in rats, the PPN has been further demonstrated to 
receive inputs from widespread brainstem areas such as the superior colliculi, 
periaqueductal gray, central tegmental field, dorsal raphe nucleus, superior raphe 
nucleus and zona incerta among others (Steininger et al., 1992). 
The diversity of electrophysiological cell types and neurochemicals involved in PPN 
signalling as well as the numerous and widespread afferent and efferent connections 
hint already at the tremendous complexity of PPN function that shall be discussed in 
the following section.  
 
Functional considerations 
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It is remarkable that initial studies from separate groups investigating different fields 
of neuroscience have indicated that the PPN is involved in two fundamental but 
apparently independent behavioural processes: arousal and locomotion. Arousal 
defines a brain state of increased sensory information processing that enables 
adequate behavioural responses, or in simple terms, it corresponds to what we can 
observe as wakefulness. In a first series of experiments by Moruzzi and Magoun, 
electrical stimulation of the reticular formation led to a conversion of the pattern of the 
electroencephalogram (EEG) from slow, high-voltage oscillations to fast, low-voltage 
activity known as “desynchronization” marking the transition from sleep to 
wakefulness (Moruzzi and Magoun, 1949). Thus, the term “reticular activating 
system” (RAS) was proposed to constitute the underlying neural substrate of arousal. 
The concept of the RAS was further developed over the next decades by findings 
that activation of thalamic cholinergic cells contributed to arousal (Steriade et al., 
1991a; Steriade et al., 1991b; Steriade et al., 1988). Based on current models, the 
neurobiological substrate of arousal constitutes a complex subcortical network with a 
number of different neurotransmitters involved. The locus coeruleus (LC) plays a key 
role in mediating arousal and maintaining wakefulness through wide-spread 
noradrenergic transmissions to the amygdala, hippocampus, hypothalamus, 
thalamus, basal forebrain and neocortex (Jones et al., 1977; Jones and Moore, 1977; 
Jones and Yang, 1985; Loughlin et al., 1986; Osaka and Matsumura, 1994; Seguela 
et al., 1990). On the level of the hypothalamus, GABAergic neurons in the 
ventrolateral preoptic area (VLPO) of the hypothalamus are active during slow-wave 
and rapid eye movement (REM) sleep while silent during wakefulness whereas 
orexin neurons of the lateral hypothalamus are active during arousal and 
wakefulness. Noradrenergic transmission from LC to the hypothalamus and dorsal 
thalamus promotes arousal by inhibiting the VLPO neurons and changing the 
thalamic firing pattern to the single spiking mode which is associated to the wakeful 
state with increased thalamocortical transmission (McCormick et al., 1991; Osaka 
and Matsumura, 1994; Szymusiak et al., 1998). Furthermore, reciprocal connections 
between the LC and the serotonergic dorsal raphe nucleus (DR) have been 
associated with regulation of the sleep-wake cycle (Kim et al., 2004; McGinty and 
Harper, 1976). As outlined before, intense efferent cholinergic and non-cholinergic 
projections from the PPN were demonstrated to reach the thalamus and lateral 
hypothalamus as well as the nucleus basalis of Meynert illustrating a possible link to 
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PPN involvement in arousal (Semba and Fibiger, 1992; Semba et al., 1988). The 
PPN projections to the thalamus are widespread including thalamocortical and 
thalamostriatal relay nuclei such as the ventral lateral thalamus and lateral geniculate 
nucleus as well as the nonspecific intralaminar nuclei such as parafascicular nucleus 
(Ainge et al., 2004; Erro et al., 1999; Kolmac and Mitrofanis, 1998). This hypothetical 
role was confirmed by findings that cells within the PPN had higher firing rates during 
wakefulness and REM sleep and the role of the PPN as a component of the RAS and 
a modulator of arousal as well as REM sleep was adopted (Boucetta et al., 2014; 
Garcia-Rill et al., 2013; Steriade et al., 1991a; Steriade et al., 1991b). However, 
lesions of cholinergic cells within the PPN failed to demonstrate an impairment of the 
waking state and the overall sleep-wake-cycle including REM sleep (Deurveilher and 
Hennevin, 2001) questioning the significance of PPN cholinergic contribution to 
modulation of the sleep-wake-cycle and arousal. More recent findings in the field 
have indicated that cholinergic neurons might help mediate brain state changes, as 
their firing rate increases transiently during the transition from sleep to wakefulness 
and after sensory stimulation before returning to baseline (Petzold et al., 2015). 
Additionally, PPN cholinergic cells have been indicated to play a role in mediating 
REM sleep, although their activation may not be a necessary prerequisite for REM 
sleep to occur (Grace et al., 2014; Van Dort et al., 2015). The intricate mechanism 
and the putative role of the PPN in mediating or modulating REM sleep is beyond the 
scope of this article and we refer to other elaborate reviews that have been published 
before (Garcia-Rill et al., 2015; Rye, 1997). 
Parallel to and independent of the discovery of a probable involvement of the PPN in 
arousal and regulation of the sleep-wake-cycle, the PPN was associated with 
locomotion. PPN has been considered in many aspects a sort of “functional portion” 
of basal ganglia since it establishes extensive and reciprocal connections with 
several basal ganglia structures as above mentioned. Furthermore, PPN participates 
to at least two critical pathways: first, it is part of the so-called mesencephalic 
locomotor region (MLR) through direct projections to the spinal cord. Thus, PPN 
should concur to provide a sort of additional locomotor release, well documented in 
cats and rodents (Garcia-Rill et al., 1987; Skinner et al., 1990a). Second, it 
contributes to ascending cholinergic projection towards the thalamic complex nuclei 
and other relay nuclei of the well-known direct or indirect pathways of the basal 
ganglia. In particular, one of the more prominent PPN-fugal output directly impinges 
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GPi and STN and it has been hypothesized the likely involvement of a “dysfunctional” 
PPN in the physiopathology of akinesia. For instance, microinjection of GABA 
receptor antagonist bicuculline, into the PPN of 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP)-treated monkeys were followed by significant 
improvement of akinesia similar to what observed with oral administration of L-3,4-
dihydroxyphenylalanine (L-DOPA) (Nandi et al., 2002a). 
Classically, the PPN and adjacent nuclei such as the cuneiform and subcuneiform 
nucleus have been suggested to comprise the MLR (Garcia-Rill, 1991). The MLR is a 
theoretical construct that was defined to help explain the findings of induction of 
movement in decerebrate cats after electrical stimulation of the pontomesencephalic 
reticular formation, especially the PPN and its associated nearby structures (Garcia-
Rill et al., 1987; Mori et al., 1978; Skinner et al., 1990b). These pioneering findings 
have engaged considerable controversies regarding PPN function in locomotion in 
the course of the following years with numerous studies presenting partly conflicting 
findings. For instance, unilateral lesioning of the PPN in the non-human primate 
induced marked motor symptoms with hypokinesia and rigidity on the contralateral 
side that endured for one to two weeks until recovery whereas bilateral lesions of the 
monkey PPN led to persistent paucity and slowness of movement (Aziz et al., 1998; 
Kojima et al., 1997; Munro-Davies et al., 1999). Similarly, high-frequency stimulation 
of the PPN caused a significant decrease in motor activity and loss of postural control 
in the macaque monkey (Pereira et al., 2008). Further evidence of the concept that 
the PPN is involved in locomotor function comes from recording experiments of 
macaques that have shown increased or decreased neuronal activity during arm 
movements and different phasic or tonic discharge patterns of PPN and cuneiform 
nucleus during locomotion on a treadmill. Of note, locomotion-responding neurons 
were located throughout the rostro-caudal extent of the PPN and cuneiform nucleus 
in both studies (Goetz et al., 2016; Matsumura et al., 1997). On the other hand, initial 
studies failed to demonstrate impaired spontaneous locomotion after lesioning the 
PPN in the rat (Inglis et al., 1994a; Inglis et al., 1994b; Keating and Winn, 2002; 
Steiniger and Kretschmer, 2004). Interestingly, more recent experiments in rats found 
that lesions of the posterior (caudal) PPN had no effect on spontaneous locomotion 
whereas lesions of the anterior PPN decreased spontaneous motor activity as 
measured by spontaneous locomotion in a red-light illuminated photocell cages. This 
finding emphasizes a functional dissociation within the PPN (Alderson et al., 2008). 
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But how can these apparently conflicting results be explained and integrated into a 
comprehensive theory of the PPN`s role in locomotor function? 
As outlined above, the PPN is interconnected with many core nuclei of the basal 
ganglia which are involved in motor control, such as the SNr and SNc, the GPI and 
the STN. Furthermore, it receives input from the cerebellar output nuclei and the 
motor and premotor cortex and it projects to the brain stem and spinal cord where it 
might influence direct motor output. Thus, based on its connectivity, the PPN is 
located in a core position to modulate key structures within the motor network. 
Numerous studies have shed a light on the intricate mechanisms how the PPN might 
be involved in motor functions. Electrophysiological studies have pointed towards 
opposite roles of cholinergic and glutamatergic neurons in movement. In experiments 
with decerebrate cats, PPN stimulation induced an acetylcholine mediated decrease 
in muscle tone and inhibition of motorneurons, while stimulation of the dorsal part, 
which contains more glutamatergic neurons elicited activity in the nucleus pontis 
oralis that was accompanied by increased muscle tone and motor activity 
(Takakusaki et al., 2016). This dichotomous role of the PPN with different influences 
of glutamatergic and cholinergic cells on locomotion has been confirmed by recent 
optogenetic experiments that demonstrated elicitation of locomotion after activation of 
PPN glutamatergic neurons, while optogentic activation of cholinergic neurons in 
mice had no such clear direct influence on locomotion (Roseberry et al., 2016). Of 
note, activation of the cholinergic neurons of the PPN improved motor symptoms 
such as gait, forelimb akinesia and overall general motor activity in freely moving 
Parkinsonian rat (Pienaar et al., 2015). A further mechanism by which the PPN exerts 
effects on behaviour and locomotion might be mediated through its extensive 
projections to the mesencephalic dopaminergic neurons comprising the SNc and 
VTA (Gould et al., 1989). Efferent projections to dopaminergic neurons originate from 
all three cholinergic, glutamatergic and GABAergic subtypes in a somatotopically 
organized manner with rostral PPN cells projecting predominantly to the SNc and 
caudal PPN neurons innervating the VTA and SNc (Charara et al., 1996; Dautan et 
al., 2016b; Gould et al., 1989; Oakman et al., 1995). Remarkably, the PPN and 
laterodorsal tegmental nucleus constitute the only cholinergic input to midbrain 
dopaminergic neurons (Dautan et al., 2016b). That this anatomical connectivity has 
an impact on behaviour and locomotion has been demonstrated in several 
independent studies. First evidence of cholinergic influence on nigrostriatal 
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dopaminergic cells came from electrophysiological studies in anaesthesized rats 
demonstrating marked changes in the firing properties of dopaminergic cells after 
stimulation of acetylcholine receptors (Lichtensteiger et al., 1982). On a behavioural 
level, nicotine (acetylcholine receptor agonist) administration to VTA neurons was 
observed to enhance drug-seeking behaviour in rats (Volkow and Morales, 2015). 
Furthermore, intra-VTA infusion of nicotine increases locomotion (Panagis et al., 
1996). The neurons of the caudal PPN (Ch5 group according to Mesulam) are the 
main source of cholinergic innervation of the VTA. Interestingly, lesions of the 
cholinergic posterior PPN in rats (caudal PPN in humans, cholinergic neurons 
containing part) but not anterior PPN lesions changed the locomotor response to 
nicotine. Thus, the caudal PPN seems to modulate at least in part locomotor activity 
by mediating cholinergic transmission to the VTA (Alderson et al., 2008; Panagis et 
al., 1996). Furthermore, optogenetic activation of cholinergic axons in the VTA 
increases locomotor activity in freely moving rats (Dautan et al., 2016b). Additionally, 
several lines of evidence indicate the PPN to play a role in dopamine mediated 
behaviours such as motivational behaviour, reinforcement and learning (Okada et al., 
2009; Pan and Hyland, 2005). For instance, distinct subpopulations of PPN neurons 
in monkeys have been demonstrated to respond differentially to predicted and actual 
reward values and further experiments in rats point towards a role of PPN neurons in 
detecting reward-prediction errors and in signalling action-outcome associations 
(Leblond et al., 2014; Okada et al., 2009; Thompson et al., 2016; Tian et al., 2016). 
Thus, several lines of evidence based on electrophysiological studies and 
behavioural tasks suggest that the PPN is involved in reinforcement learning and 
reward circuits. By its modulatory effect on mesencephalic dopaminergic neurons, 
the PPN is believed to influence behavioural decision-making by direct and indirect 
regulation of striatal activity (Mena-Segovia and Bolam, 2017). However, the 
underlying mechanisms by which the PPN receives sensory input about 
behaviourally relevant stimuli remain unclear and need to be further investigated. 
Furthermore, the role that different neuronal subpopulations within the PPN play in 
these processes need to be elucidated.  
It is possible that the diversity and partly conflicting results obtained by different 
groups and in different species are due to lesions and recordings of different PPN 
sectors during the diverse experimental set-ups as well as the different outcome 
measures used to determine motor activity. Nevertheless, growing evidence 
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suggests, that the PPN seems to have numerous and complex effects on the control 
of behaviour and locomotion depending on the cell type and location within the PPN. 
Whereas descending cholinergic fibers seem to decrease motor activity in the brain 
stem nuclei and spinal cord inhibiting ongoing movement, ascending projections 
mediated by acetylcholine and glutamate might promote goal-directed behaviour by 
increasing dopamine transmission to the striatum. Furthermore, the PPN is densely 
interconnected with the STN, which itself exerts powerful excitatory control on the 
GPi, the main inhibitory output nucleus of the basal ganglia. Whether the PPN 
determines if the STN breaks ongoing basal ganglia activity remains to be 
investigated (Gillies and Willshaw, 1998).  
 
The role of the PPN in movement disorders 
Apart from studies on decerebrate vertebrates, the vast amount of the above 
presented studies are based on animal models with a healthy, non-diseased brain 
and therefore indicate a crucial contributory role of the PPN in attention, motivation 
and goal-directed behaviour as well as locomotion in the normally functioning brain. 
Another important line of evidence suggested that the PPN may be involved in the 
pathophysiology of degenerative movement disorders such as PD, progressive 
supranuclear palsy and multisystem atrophy. In 1987, Hirsch and colleagues reported 
that the cholinergic Ch5 cell group corresponding to the PPN undergoes 
degeneration in idiopathic PD and in the parkinsonian syndrome of progressive 
supranuclear palsy (Hirsch et al., 1987). The authors already hypothesized that 
certain symptoms of these movement disorders have their genesis in the pathology 
of these cholinergic neurons. These results were confirmed by findings of Zweig and 
coworkers and the loss of cholinergic cells within the PPN was later shown to be 
correlated with the severity of Parkinsonian symptoms (Rinne et al., 2008; Zweig et 
al., 1989; Zweig et al., 1987).  
The potential role of the PPN in the pathophysiology of degenerative movement 
disorders was further characterized in animal models of non-human primates. The 
discovery that the compound 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 
induces parkinsonism in humans led to its application in primate models of PD for 
research purposes which has been proven to be a powerful animal model of PD 
which exhibits main features of human PD such as resting tremor and drug-induced 
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dyskinesias (Burns et al., 1983; Langston et al., 1983; Langston et al., 2000). In 
1989, Mitchell and colleagues investigated MPTP-treated monkeys and found an 
altered pattern of abnormal neuronal activity in basal ganglia circuitry with increased 
activity in neurons of the medial segment of the globus pallidus (GPi) projecting to the 
pedunculopontine nucleus (Mitchell et al., 1989). Furthermore, metabolic markers are 
downregulated in the PPN in the MPTP treated monkey accompanied by decreased 
synthesis of acetylcholine (Gomez-Gallego et al., 2007). Given the fact that the main 
output of the internal pallidal segment is mediated by the inhibitory neurotransmitter 
GABA, it was hypothesized that chronic inhibition of the PPN driven by an overactive 
GPi contributed to the pathophysiological process underlying motor symptoms of PD 
such as bradykinesia and gait control. In support of this idea, direct injection of the 
GABA-agonist muscimol into the PPN in a normal monkey reduced significantly the 
motor activity of the animal whereas injection of the GABA antagonist bicuculine into 
the PPN of a MPTP-treated monkey reversed akinesia (Nandi et al., 2002a). Findings 
that unilateral lesioning of the PPN led to temporary Parkinsonian symptoms on the 
contralateral side in monkeys, whereas bilateral lesions led to marked persistent 
akinesia further supported the concept that the PPN is involved in the 
pathophysiology of PD and associated movement and gait disorders (Aziz et al., 
1998).  
Motivated by these findings that pointed towards a potential new target for 
neuromodulation therapy, a number of stimulation experiments in primates were 
conducted in the following period. Stimulation after bilateral implantation of DBS 
leads into the PPN of an intact macaque under ventriculographic guidance led to 
motor effects that were frequency-dependent. Whereas low-frequency stimulation (5-
10 Hz) caused tremor on the contralateral side, high-frequency stimulation (45-100 
Hz) caused reduced motor activity and impaired postural control of the animal (Nandi 
et al., 2002b). On the other hand, in the MPTP-treated monkey low-frequency 
stimulation of bilaterally implanted DBS leads into the PPN improved motor activity, a 
finding that was interpreted as a proof-of-principle of DBS to treat Parkinson`s 
disease and gait disorders (Jenkinson et al., 2005; Jenkinson et al., 2004; Jenkinson 
et al., 2006).  
 
Deep brain stimulation of the PPN in humans 
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The theoretical background and the encouraging stimulation experiments of the PPN 
in Parkinsonian monkeys at the beginning of the millennium prompted the first 
application attempts of PPN-DBS in patients with PD and the first two case reports by 
Plaha et al and Mazzone et al. were published as early as 2005 (Mazzone et al., 
2005; Plaha and Gill, 2005). In both cases low-frequency stimulation of 10-25 Hz 
after bilateral PPN electrode implantation were reported to alleviate predominantly 
PD axial symptoms and no major side-effects were observed. These observations led 
the authors to conclude that the PPN might be a new target to treat axial symptoms, 
that otherwise only respond poorly to dopaminergic therapy and DBS of the STN and 
GPi. Since these first reports on successful DBS implantation of the PPN, a number 
of other case reports and studies including a small number of patients have been 
published leading to fewer than 100 cases of PPN-DBS so far (Thevathasan et al., 
2017). The first enthusiasm about this potential new target was soon dampened by 
the mixed and sometimes disappointing outcomes found between different and even 
within single centers (Morita et al., 2014). However, more than 10 years of 
experience with PPN-DBS have certainly broadened the understanding of the 
complexity of the issue. Reviewing the literature enables us to identify which patients 
might profit from PPN-DBS and to appreciate what can be expected and what cannot 
be expected from PPN-DBS in terms of outcome. Furthermore, factors that might 
have an impact on the success of PPN-DBS are about to be elucidated. 
 
PPN-DBS study results in humans: motor outcome 
A heterogeneous dataset including case reports, open label series, double-blinded 
single time point assessments, and longer term double-blinded studies have been 
published so far. Table 1 summarizes key studies with at least 5 subjects. These 
studies define the basis upon which first conclusions about the clinical effectiveness 
of PPN-DBS can be drawn. Before discussing the findings of the studies, it is 
important to acknowledge the limitations and confounds from these studies: table 1 
points to a pivotal issue that makes the interpretation of the results challenging if not 
impossible due to the heterogeneous study designs, different outcome measures 
used to assess freezing of gait (FOG), falls and postural instability as well as the 
variability of the DBS settings including unilateral PPN-DBS, lone bilateral PPN-DBS 
and combined bilateral PPN-DBS with other targets such as the caudal Zona incerta 
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(cZI) or Subthalamic nucleus (STN). Furthermore, the targeting strategy and 
stimulation site within the PPN varies considerably between studies. For instance, 
active contact positions were distributed throughout the rostro-caudal axis between 
studies. Additionally, the differences between the exact stimulation site and 
costimulation with other targets are accompanied by varying stimulation parameters 
(Ferraye et al., 2010; Khan et al., 2012; Khan et al., 2011; Mestre et al., 2016; Moro 
et al., 2010; Stefani et al., 2007; Thevathasan et al., 2011a; Thevathasan et al., 
2012; Welter et al., 2015). Despite this inhomogeneity, table 1 shows a clear trend 
towards a reduction in axial symptoms of PD patients especially towards an 
improvement FOG and falls in the majority of patients. This mean reduction in 
postural instability, FOG and the number of falls was recently confirmed by two meta-
analyses, although the inhomogeneity of study designs, stimulation paradigms and 
stimulation sites as well as confounders of co-stimulation necessitates very cautious 
interpretation of compound data. Furthermore, these positive effects on postural 
stability and gait are variable between studies and even within studies. It seems that 
some patients profit while others do not.  
There are different possible explanations for the inconsistency of results. First of all, it 
is difficult to assess and quantify axial PD signs such as postural instability, FOG and 
falls. For instance, the “pull test” item of the Unified Parkinson´s Disease Ranking 
Scale (UPDRS) is the only method used by most studies to assess postural 
instability. However, it is poorly reliable and highly depends on the examiner. On the 
other hand, to assess FOG and falls, most studies relied on questionnaires which are 
prone to recall bias (Ferraye et al., 2010; Thevathasan et al., 2011a). Other studies 
used objective laboratory methods to analyse spatiotemporal gait patterns (Peppe et 
al., 2010; Stefani et al., 2007; Thevathasan et al., 2012). However, the fluctuating 
quality of FOG and its propensity for disappearing under observation restrict the 
validity of such elaborate methods. Second, the stimulation site differed between 
studies. While some studies targeted the caudal PPN, active contact position was 
distributed along the rostrocaudal axis in other studies (summarized in table 1). From 
anatomical and functional considerations based on animal experiments, the PPN is 
not a homogenous structure but seems to have different, anatomically and 
functionally segregated parts (Alderson et al., 2008; Dautan et al., 2016b; Takakusaki 
et al., 2016). In line with this premise, first evidence from neurophysiological studies 
in humans confirmed such a somatotopy: oscillations in the alpha band measured in 
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the caudal part of the PPN were found to correlate with gait and freezing whereas 
beta band oscillations in the rostral part of the PPN did not (Tattersall et al., 2014; 
Thevathasan et al., 2012). Thus, very limited data points towards the hypothesis that 
stimulation of the caudal PPN is clinically more effective in reducing FOG than 
stimulation of the rostral PPN (Thevathasan et al., 2012). However, there are still 
controversies about this (Hamani et al., 2016b). 
Contrary to axial symptoms and FOG, other symptoms such as tremor, akinesia and 
rigidity do not seem to respond to PPN-DBS. The great majority of the studies found 
no significant reduction in the overall motor UPDRS part III (Ferraye et al., 2010; 
Moro et al., 2010; Thevathasan et al., 2011a; Thevathasan et al., 2012; Welter et al., 
2015). Positive effects of PPN-DBS on the total motor UPDRS III score were only 
repeatedly reported by open-label studies of one group including 1 to 7 patients and 
by one prospective double-blind study of 6 patients (Khan et al., 2012; Khan et al., 
2011; Plaha and Gill, 2005; Stefani et al., 2007). Furthermore, in contrast to DBS of 
the STN for PD, PPN-DBS enabled no reduction of dopaminergic therapy in all those 
studies reporting on L-DOPA equivalent doses (Moro et al., 2010; Thevathasan et al., 
2011a; Welter et al., 2015). 
Another important feature of PPN-DBS with reference to its motor effects is the long 
latency for clinical benefits to occur. Unlike stimulation of the STN, there are no 
immediate observable effects after switching on and off the neurostimulator in case of 
PPN-DBS. Furthermore, some centres described carry-over effects after chronic 
stimulation lasting for days to weeks (Ferraye et al., 2010). This does not only have 
theoretical implications for the study design when incorporating stimulation-on and 
stimulation-off phases to evaluate clinical effects, but also for clinical purposes and 
stimulation parameter adjustment. The unpredictable, fluctuating nature of gait 
freezing and the long latencies of stimulation parameter adjustments makes DBS 
programming of the PPN a complex and time-consuming procedure (Thevathasan et 
al., 2017). All studies found that low-frequency stimulation of the PPN was optimal to 
alleviate motor symptoms (see table 1). However, the frequencies varied 
considerably between studies and ranged from 15-70 Hz depending on the co-
stimulation with other targets. Again, the inhomogeneity between studies in terms of 
stimulation paradigms prevents from drawing further conclusions about the optimal 
stimulation parameters. 
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PPN-DBS study results in humans: side effects and non-motor impact 
Clinical application of bilateral PPN-DBS has been demonstrated to be clinically safe. 
Though, when it comes to the most dreaded complication in DBS, namely a surgery-
related haemorrhage, the impact can be disastrous and lead to permanent 
dependency of the patient (Welter et al., 2015). Side effects, which are stimulation-
dependent can be explained by current-spread and consecutive activation of the 
neighbouring anatomical structures. These encompass contralateral paraesthesia, 
that typically habituate over seconds to minutes and which are explained by current 
spread to the medial lemniscus (Ferraye et al., 2010; Stefani et al., 2007). Painful 
sensations may reflect activation of the more posterior located spinothalamc fiber 
tract (Hazrati et al., 2012). Oscillopsia is another regularly described phenomenon 
that clinically goes along with ipsilateral nystagmus and has been attributed to 
stimulation of the cerebellothalamic fibers within the superior cerebellar peduncle 
(Jenkinson et al., 2012). Stimulation of the latter has been further associated with 
limb myoclonus (Ferraye et al., 2010). Urge incontinence attributed to stimulation of 
the pontine micturition centre was described in one patient (Aviles-Olmos et al., 
2011). Further investigation into this phenomenon with urodynamic testing found no 
detrimental effects on urodynamic filling parameters and detrusor activity but a slight 
increase in maximal bladder capacity (Roy et al., 2017).  
That the cholinergic transmission originating from the PPN may play a role in 
mediating brain state changes and mediate arousal, attention and REM-sleep control 
was outlined above. The question if stimulation of the PPN as part of the so-called 
RAS also has clinical implications has been addressed, especially because gait 
deficits and falls are at least in part attributable to attentional deficits (Giladi and 
Hausdorff, 2006). To date, there is no evidence of impaired cognitive function after 
PPN DBS, on the contrary, some studies found a positive effect on frontal lobe 
function and reaction time (Ferraye et al., 2010; Thevathasan et al., 2011b; 
Thevathasan et al., 2010; Welter et al., 2015). Moreover, the possible impact of PPN 
stimulation on sleep in patients with PD was addressed by three studies. These 
studies found that PPN DBS affected the switching between sleep stages and 
promoted REM sleep (Alessandro et al., 2010; Arnulf et al., 2010; Lim et al., 2009). 
Using polysomnography in 5 PD patients undergoing unilateral PPN-DBS Lim and 
ACCEPTED MANUSCRIPT
AC
C
EP
TE
D
 M
AN
U
SC
R
IP
T
 
 
co-workers demonstrated a near doubling of nocturnal REM sleep episodes between 
the DBS "off" and DBS "on" states, without significant changes in other sleep states. 
This is particularly noteworthy as REM sleep disorders are a common symptom in PD 
patients (Bassetti and Bargiotas, 2018; Di Fabio et al., 2013). However, it remains 
unclear if these observations of PPN-DBS induced increases in the frequency of 
REM sleep episodes have any clinical significance. 
Missing or weak effects of PPN stimulation due to the complex intrinsic functional and 
anatomical segregation of the small nucleus on the one hand and induction of side 
effects due to current spread to the surrounding fiber pathways on the other hand 
might be improved by future applications of electrodes with an altered design. 
Smaller electrodes and current steering technologies might increase the specification 
of stimulation in this area, similarly to what has been demonstrated in other target 
structure such as the STN(Contarino et al., 2014; Pollo et al., 2014; Steigerwald et 
al., 2016).  
Targeting strategies of the PPN 
Similar to the differences in study designs and co-stimulation with other targets, there 
is considerable variability in the targeting strategies used by different groups. 
Targeting methods include both direct targeting strategies based on identification of 
the target structure based on landmarks depictable on the patient`s MRI or indirect 
targeting strategies based on coordinates derived from human brain atlases. Thus 
methodology ranged from sole T2-weighted MRI-based direct targeting under general 
anaesthesia, combination of MRI-based and stereotactic CT-based targeting as well 
as loan stereotactic CT- or ventriculography-based targeting incorporating 
information from a stereotactic atlas of the human brain stem (Ferraye et al., 2010; 
Plaha and Gill, 2005; Stefani et al., 2007; Thevathasan et al., 2011a; Weinberger et 
al., 2008). Some groups used intraoperative microelectrode recording for target 
confirmation, while others did not (Ferraye et al., 2010; Khan et al., 2012; 
Thevathasan et al., 2011a). A detailed discussion about the different targeting 
approaches and results of microelectrode recordings is beyond the scope of this 
review and can be found in other excellent reviews (Hamani et al., 2016a; Hamani et 
al., 2016b). Only a few points shall be highlighted in the context of this review: as 
already outlined above, there is considerable variability of the exact location and 
borders of the PPN between different brainstem atlases. This might be attributed to 
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the fact that the PPN is a reticular nucleus with indistinct boundaries and has 
important implications on atlas-based targeting and further contributes to the difficulty 
to exactly localize implanted electrodes. With respect to direct targeting based on 
MRI, the PPN can be detected (indirectly) in the context of surrounding structures: 
lateral to the cerebellar peduncle and medial to the medial lemniscus at the level of 
the pontomesencephalic junction. By applying T1- and Proton-weighted sequences, 
Zrinzo and colleagues compared atlas-based coordinates and MRI images of 12 
patients and found significant differences between the predicted PPN coordinates 
based on atlases and the PPN position found on MRI (Zrinzo et al., 2008). These 
differences were especially pronounced in the rostro-caudal axis. This study 
underlines the high individual variability of the exact anatomical location of the PPN 
and the shortcomings of atlas-based targeting technique not to account for this 
variability. However, the MRI borders of the PPN and nearby structures also cannot 
be delineated with certainty in many cases especially in patients with degenerative 
processes of the PPN (Mazzone et al., 2016; Yelnik, 2007). More recently, diffusion 
tensor imaging has been proposed to help guide targeting by better visualizing the 
neighbouring fiber tracts (Alho et al., 2017). If DTI-based targeting strategies improve 
accuracy and outcome, has to be shown in future studies.  
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PPN-DBS in humans: who can profit? 
Despite more than 10 years of clinical experience with DBS of the PPN, the number 
of implanted patients remains limited and outcome varies to a considerable extent. 
Attributable factors have been discussed and include high variability of clinical 
methodology, difficulties of outcome assessment as well as distinct underlying patient 
characteristics throughout different studies. Despite these numerous limitations of 
current data, there is a clear trend that PPN has the potential to improve FOG and 
reduce falls in some patients. Factors that may predict outcome are currently not 
known. On the other hand, PPN-DBS does not seem to improve other aspects of PD 
such as tremor, rigor and akinesia and does not allow a reduction of dopaminergic 
medication. Gathering the available information, there are two PD patient profiles that 
might best respond to PPN-DBS. First, patients with early-onset and severe 
medication resistant gait freezing are candidates for sole PPN-DBS (Giladi and 
Hausdorff, 2006). This unusual subgroup only consists of around 5% of patients with 
PD. Patients suffering from medication-responsive gait freezing and motor 
fluctuations, however, qualify for classical STN and GPi DBS (Deuschl et al., 2006; 
Follett et al., 2010). Patients with PD who develop therapy-resistant gait freezing 
despite STN and GPi DBS can be candidates for co-stimulation with PPN (Ferraye et 
al., 2010; Khan et al., 2012; Stefani et al., 2007; Thevathasan et al., 2011a). 
 
Concluding remarks 
The classical ideas about the PPN which was primarily associated with the key words 
“mesencephalic locomotor region” and the “reticular activating system” have been 
refined to a considerable extent over the past few decades. The PPN has been 
appreciated as an inhomogeneous reticular nucleus of the pontomesencephalic 
tegmentum that features intricate neuroanatomical, neurochemical and 
neurophysiological properties. Its intense anatomical connectivity with key 
components of the basal-ganglia, cerebellum, thalamus, midbrain dopaminergic 
nuclei, brainstem motor nuclei and spinal cord puts it into a central position to 
modulate a variety of functions such as reward prediction error coding, motivational 
and goal-directed behaviour, locomotion, attention and regulation of the sleep-wake-
cycle. The overall complexity which is condensed into a comparatively small neuronal 
assembly of a few millimetres in diameter needs to be acknowledged if we intend to 
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modulate subcomponents of its many functions by applying DBS to treat gait 
disorders in PD patients. Certainly more details about the intricate organization of the 
PPN and ways to target more accurately clinically effective subterritories of the PPN 
must be found out until we can appreciate its full clinical potential. Notwithstanding 
these constraints, the clinical findings that early-onset gait disturbances as well as 
therapy resistant gait freezing despite STN/GPi-stimulation may benefit from 
additional low-frequency stimulation of the PPN shall motivate for the conduct of 
future research and clinical trials. The latter ones have to take account of the 
difficulties for proper targeting as well as meaningful assessment of clinical outcome. 
Improvement of imaging, down-scaling and steering of the stimulation area by use of 
directional leads in order to improve the therapeutic window as well as utilization of a 
dedicated scale to assess gait disturbances and freezing might be important and 
encouraging future factors to help disentangle the complex and ambitious enterprise 
to understand and achieve clinically relevant effects of PPN-DBS. 
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Table 1: cZI, caudal Zona incerta; FOG, freezing of gait; GFQ, gait and falls questionnaire; PDQ-39, 
 Parkinson`s disease Quality of Life; RSGE, rating scale for gait evaluation
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STN alone 
in UPDRS 
III axial 
subscore 
reduction 
in ON-med 
as well as 
ADL 
scores 
Ferraye et 
al.; 2010; 
Grenoble 
6 bilat. STN + 
PPN 
(consecutiv
ely) 
Caudal 
and 
rostral 
PPN 
15-25 Hz, 
60-90 µs, 
1.2-3.8 V 
Doubl
e-
blind 
(6 
month
s) 
Open-
label 
(12 
month
s) 
6 
month
s and 
12 
month
s 
UPDRS, 
FOGQ, 
PDQ-39 
- no 
changes of 
UPDRS in 
double-
blind 
phase 
- 
improvem
ent of gait 
(2 of 6) at 
1 year 
- 
improvem
ent of 
FOG (4 of 
6) at 1 
year 
Khan et 
al.; 2011 
and 2012; 
Bristol 
7 bilat. cZI + 
PPN 
PPN (not 
specified) 
60 Hz; 60 
µs; 2.6 V 
Open-
label 
12 
month
s 
UPDRS 
III; 
PDQ-39 
- PPN + 
cZI 
significantl
y improved 
UPDRS III 
axial 
subscore 
compared 
to PPN 
and cZI 
alone in 
ON-med  
Thevathas
an et al.; 
2011a; 
Brisbane 
5 bilat. PPN Caudal 
PPN 
35 Hz; 60 
µs; 3.5 V 
Open-
label 
24 
month
s 
UPDRS; 
GFQ 
- GFQ 
scores 
improved 
in all 
patients; 
fewer falls 
- Off-med 
UPDRS 
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axial 
scores 
improved 
Thevathas
an et al.; 
2012; 
Oxford, 
London 
7 bilat. PPN Caudal 
PPN 
35-40 Hz, 
60 µs; 
1.8-3.5 V 
Single
-
sessio
n 
doubl
e blind 
2-30 
month
s 
UPDRS 
II + III; 
GFQ 
- GFQ 
score 
improved 
significantl
y 
Welter et 
al.; 2015; 
Paris 
6 bilat. PPN Cuadal 
and 
rostral 
PPN 
20-40 Hz; 
60 µs; 
1.3-3.1 V 
Doubl
e-
blind 
6 
month
s 
RSGE, 
UPDRS 
II and III 
composi
te gait 
score, 
PDQ-39 
- 
brainstem 
hemorrhag
e in 1 
patient 
- reduced 
FOG in 3 
of 4 
patients 
- PDQ-39 
improved 
significantl
y 
Mestre et 
al.; 2016; 
Toronto 
9 unilat. PPN Caudal 
and 
rostral 
PPN 
50-70 Hz; 
60-120 
µs; 1-3.5 
V 
Doubl
e-
blind 
24-48 
month
s 
UPDRS 
II and III 
axial 
scores 
- 
Improvem
ent in falls 
and 
freezing in 
5-6/8 
patients 
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Figure legends 
 
Figure 1: Schematic (A, B) and corresponding ChAT-immunostained microscopical 
(C, D) views of the Pedunculopontine nucleus and its anatomical relationship in the 
midbrain tegmentum at the level of the inferior colliculus (A, C) and at the level of the 
trochlear nucleus and intercollicular area (B, D). The ChAT-immunostained 
microscopical images demonstrate the subdivision of the nucleus into a compact and 
reticular part with its weakly defined boundaries. The curved arrows point to some of 
the interstitial ChAT-positive neurons in the diffuse part of Ch5 (Ch5d). 
CA, cerebral aqueduct; cg = central grey; Ch5c = compact part of group 5 cholinergic 
neurons; Ch5d = dense part of group 5 cholinergic neurons; Ch6 = group 6 
cholinergic neurons; CN/nc = cuneiform nucleus; ctt/CTT = central tegmental tract; 
Dec SCP = decussation of the superior cerebellar peduncles; dr/NRD = dorsal raphe 
nucleus; LC = locus coeruleus; LL = lateral lemniscus; ML = medial lemniscus; MLF = 
medial longitudinal fasciculus; PAG = periaqueductal gray; PN = pontine nuclei; 
ppc/PPNc = compact part of the pedunculopontine nucleus; PPNd = 
pedunculopontine nucleus pars dissipata; scp = superior cerebellar peduncle; SNc = 
substantia nigra pars compacta; STT = spinothalamic tract; RST = rubrospinal tract; 
tn/IV = trochlear nucleus; V = mesencephalic nucleus of the trigeminal nerve; v IV= 
4th ventricle. 
(Figure 1 A,B is adapted from Fournier-Gosselin et al. 2013 (Fournier-Gosselin et al., 
2013), Figure 1 C, D is adapted from Mesulam et al. 1989 (Mesulam et al., 1989) with 
kind permission of the authors). 
 
Figure 2: Connectivity map of the Pedunculopontine nucleus. Afferent connections 
are displayed in black, efferent cholinergic connections are displayed in blue, efferent 
GABAergic connections are displayed in yellow, efferent glutamatergic connections 
are displayed in red. The connectivity map represents current knowledge and is not 
intended to be exhaustive. Ach = acetylcholine; AMY = amygdale; GABA = gamma-
aminobutyric acid; Glu = glutamate; Gig cell = Gigantocellular nucleus; GP = Globus 
pallidus; PAG = periaqueductal grey matter; Pon. ora. = Pontinus oralis nucleus; PPN 
= Pedunculopontine nucleus; Raphe nucl. = Raphe nuclei; SNc = substantia nigra 
compacta; SNr = substantia nigra reticulata; STN = Subthalamic nucleus; sup. Coll. = 
superior colliculus; VTA = ventral tegmental area. 
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